Advertisement
Clinuvel Pharmaceuticals Limited

Clinuvel Pharmaceuticals Limited (CLVLY) Stock Competitors & Peer Comparison

See (CLVLY) competitors and their performances in Stock Market.

CLVLYPNK
HealthcareBiotechnology
$6.26
$0.06(0.97%)
U.S. Market opens in 10h 58m
Advertisement

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
CLVLY$6.26+0.97%315.4M13.90$0.45+0.50%
NONOF$44.00+4.74%197.1B10.42$4.26+4.07%
CSLLY$19.06-0.73%73.9B12.40$1.54+3.79%
UCBJF$321.05+3.56%61.1B34.67$9.26+0.53%
UCBJY$158.72+0.54%60.3B34.23$4.63+0.54%
ARGNF$900.00+1.69%55.7B40.04$22.48N/A
CMXHF$74.14-0.04%35.5B12.02$6.17+3.94%
WXIBF$4.40+0.00%18.2B25.88$0.17N/A
IVBXF$9.79-9.01%17B139.86$0.07N/A
WXXWY$7.89+4.46%16.3B23.34$0.34N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

CLVLY vs NONOF Comparison June 2026

CLVLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CLVLY stands at 315.4M. In comparison, NONOF has a market cap of 197.1B. Regarding current trading prices, CLVLY is priced at $6.26, while NONOF trades at $44.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CLVLY currently has a P/E ratio of 13.90, whereas NONOF's P/E ratio is 10.42. In terms of profitability, CLVLY's ROE is +0.13%, compared to NONOF's ROE of +0.66%. Regarding short-term risk, CLVLY is more volatile compared to NONOF. This indicates potentially higher risk in terms of short-term price fluctuations for CLVLY.Check NONOF's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions